Mode of Action of Kanglemycin A, an Ansamycin Natural Product that Is Active against Rifampicin-Resistant Mycobacterium tuberculosis. (2018)

First Author: Mosaei H
Attributed to:  Novel antibiotics targeting bacterial gene expression funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.molcel.2018.08.028

PubMed Identifier: 30244835

Publication URI: http://europepmc.org/abstract/MED/30244835

Type: Journal Article/Review

Volume: 72

Parent Publication: Molecular cell

Issue: 2

ISSN: 1097-2765